Nifty Pharma index rises 2% as Sun Pharma, Lupin receive USFDA approval
.jpg)
Shares of pharmaceutical companies were in focus with the Nifty Pharma index rising over 2 per cent to 10,623.60 levels in the intra-day deals after Sun Pharmaceutical Industries (Sun Pharma) and Lupin USFDA approval for their respective medicines.
Sun Pharma rose over 3 per cent to an intra-day high of Rs 670.90 on the National Stock Exchange (NSE) after the drug maker announced USFDA approval of XELPROS to treat open-angle Glaucoma or Ocular Hypertension. This approval is from Sun Pharma’s Halol facility.
"XELPROS is the first and only form of latanoprost that is not formulated with benzalkonium chloride (BAK), a preservative commonly used in topical ocular preparations. XELPROSTM is developed using SPARC’s proprietary Swollen Micelle Microemulsion (SMM) technology." it said in a BSE filing earlier today.
On the other hand, Lupin, too, rose 2 per cent to Rs 978.75 on the NSE after the company on Wednesday said it has received nod from the US health regulator to market its Atovaquone oral suspension used for prevention and treatment of a type of pneumonia.
The company has received approval to market generic Atovaquone oral suspension USP in the strength of 750 mg/5 mL from the United States Food and Drug Administration (USFDA), Lupin said in a BSE filing.
At 10:05 am, all the stocks in the Nifty Pharma index were trading higher in the range of 1 per cent to 4 per cent.
Other Latest News
.webp)
Tripura Chief Minister Manik Saha said on Friday that the state government has undertaken a multi-pronged plan for the development of tourism in Tripura. He said a Memorandum of Understanding (MoU) worth Rs 692 crore has been signed by the Tripura Tourism Department for the construction of ropeways.
Dr Saha made this announcement while addressing the World Tourism Day 2024 programme and felicitation of the unsung heroes of the recent floods in Tripura at Rabindra Shatabarshiki Bhawan.
.webp)
A petition has been filed in the High Court of Karnataka, seeking a CBI probe against Chief Minister Siddaramaiah in connection with the alleged MUDA scam.
Advocate Vasant Kumar, representing petitioner activist Snehamayi Krishna on Friday said that they have filed a writ petition and are seeking High Court directions to handover the case to the CBI to carry out a fair investigation in the writ petition.
.webp)
About 12 textile companies are set to receive the first set of incentive payment under the production-linked incentive (PLI) scheme.
“Around 40 companies have grounded investment. We had a gestation period till March 2024.We hopethis financial year 10-12 companies will be getting incentive payout (under PLI),” a senior government official said on Friday.
.webp)
The Punjab Bharatiya Janata Party (BJP) on Friday confirmed that Sunil Jakhar continues to lead the party in the state, calling rumours of his resignation "totally baseless". Punjab BJP general secretary Anil Sarin confirmed that Jakhar, 70, was leading the party.
The BJP’s reaction followed hours after media reports claimed that Jakhar had reportedly resigned. The news had particularly raised eyebrows in view of the upcoming panchayat elections in the state scheduled for October 15.
.webp)
Shares of Vedanta have continued their upward trajectory to hit a new high of Rs 515.85, after gaining 3 per cent on Friday’s intra-day trade, on the BSE.
The stock of the Anil Agarwal-promoted company has rallied 8 per cent in two days, after it announced the schedule of a board meeting to consider the fourth interim dividend for FY25.
.webp)
.webp)
.webp)
.webp)
.webp)
